pharmaceuticalslabradio-1024x683

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the years, the nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The market is in its growth phase with an increasing number of radioisotope approvals for different clinical indications. Ra-223, I-131, and Y-90 ensured their leading position in the nuclear medicine therapeutic market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the products and services offered by top players in the nuclear medicine/radiopharmaceuticals market. The report analyzes the nuclear medicine/radiopharmaceuticals market by type, application, procedural volume, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the nuclear medicine/radiopharmaceuticals market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for nuclear medicine/radiopharmaceuticals across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the nuclear medicine/radiopharmaceuticals market
Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the nuclear medicine/radiopharmaceuticals market

Download Report Sample @ https://www.grandresearchstore.com/report-sample/nuclear-medicine2Fradiopharmaceuticals-market-by-type-diagnostic-spect—technetium-pet—f-18-therapeutic-beta-emitters—i-131-alpha-emitters-brachytherapy—y-90-26-by-application-oncology-thyroid-cardiology—global-forecasts-to-2021

Table Of Contents:

1 INTRODUCTION 15

2 RESEARCH METHODOLOGY 19

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 33

5 MARKET OVERVIEW 36

6 INDUSTRY TRENDS 46

7 MACROECONOMIC OVERVIEW AND KEY TRENDS 50

8 AEROSPACE COMPOSITES MARKET, BY FIBER TYPE 56

9 AEROSPACE COMPOSITES, BY RESIN TYPE 65

10 AEROSPACE COMPOSITES MARKET, BY AIRCRAFT TYPE 75

For More Details VISIT @ https://www.grandresearchstore.com/pharmaceuticals/nuclear-medicine2Fradiopharmaceuticals-market-by-type-diagnostic-spect—technetium-pet—f-18-therapeutic-beta-emitters—i-131-alpha-emitters-brachytherapy—y-90-26-by-application-oncology-thyroid-cardiology—global-forecasts-to-2021

Advertisements